Soligenix (NasdaqCM:SNGX) Earnings Call Presentation

Rising to the Challenges of Rare Disease Treatment NASDAQ: SNGX March 27, 2026 Forward-Looking Statements This presentation contains forward-looking statements. All statements other than statements of historical facts contained in this presentation, including statements regarding our future results of operations and financial position, business strategy, prospective products and product candidates and their development, regulatory approvals, ability to commercialize our products and product candidates and a ...